Rush Alzheimer's Disease Research Center
Rush Alzheimer's Disease Research Center
批准号:
10264493
负责人:
DAVID ALAN BENNETT
金额:
$312.77万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2026-06-30
关键词:
AgingAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAutopsyBiologicalBiological MarkersBiometryBrainCaregiversCell modelClergyClinicalCohort StudiesCommunitiesCrystallizationDataData CollectionData SetDementiaDisease modelEducationEnrollmentEvaluationExerciseFacultyFundingGoalsGrantHeterogeneityHumanImpaired cognitionIncentivesInfrastructureInstitutionLatinoLeadershipMagnetic Resonance ImagingMethodologyMolecular ProfilingNatureOrgan DonationsParticipantPathogenesisPatientsPersonsPilot ProjectsPositron-Emission TomographyPreventionProceduresProcessPublishingRecommendationReproducibilityResearchResearch PersonnelResearch Project GrantsResourcesScienceSourceSpecimenStrategic PlanningStructureSystems BiologyTrustWorkcohortcollaborative environmentcommunity based researchcomputer infrastructurecomputerized toolsdata harmonizationdata managementdata sharingdistributed dataeducation researchethnic minority populationfollow-uphuman datainnovationmultidisciplinaryneuroimagingneuroimaging markerneuropathologynew therapeutic targetopen dataoutreachpredictive modelingprogramspublic health prioritiespublic-private partnershipracial and ethnicracial diversityracial minorityrecruitrelational databasereligious order studyrepositorystatisticsstudent mentoringvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT – OVERALL
The overall goal of the proposed Rush ADRC is to create an inter-disciplinary environment that supports
innovative research on the causes, treatments, and prevention of AD/ADRD. While the proposed Rush ADRC
is for a new grant, it builds on three decades of work by the current Rush ADCC. The Rush ADRC has eight
cores and one component, which align with the recommendations of the 2017 NIA strategic plan, including
studies that: 1) recognize the heterogeneity and multifactorial nature of dementias; 2) support extensive
molecular profiling to fill the gaps in large-scale human data needed to build predictive models of disease and
wellness; 3) employ new research paradigms, e.g., systems biology, human cell modeling; 4) enable rapid and
extensive sharing of data, disease models, specimens, and support open and team science; 5) develop
computational tools and infrastructure for storage, integration, and analysis of large-scale biological and
patient-relevant data; 6) build multidisciplinary translational teams in virtual and real spaces; 7) develop new
pre-competitive public-private partnerships; 8) change academic, publishing, and funding incentives to promote
collaborative, transparent, and reproducible research; and 9) engage patients, caregivers, and citizens as
direct partners in research.
The Administrative Core will provide scientific leadership to the Rush ADRC as a whole. The Religious Orders
Study (ROS) Core will recruit and conduct annual evaluations of Catholic clergy without dementia who agree to
organ donation. The Clinical and Latino Cores will collect data harmonized with on Blacks and Latinos without
dementia and work to obtain brain autopsy. The Neuropathology Core will process, store, evaluate and
distribute biospecimens obtained by the Clinical, ROS, and Latino Cores. The Outreach, Recruitment, and
Engagement Core will provide a wide range of educational programs to support outreach and recruitment of
racial and ethnic minorities into the Clinical, ROS and Latino Cores, and other NIA funded initiatives. The
Biomarker/Neuroimaging Core will process neuroimaging generated with other funds from all three Cores and
affiliated studies, and document neuroimaging and biofluid biomarker data. The new Research and Education
Component will provide structured mentoring of students and faculty at all levels. The Data Management and
Statistical Core will provide the infrastructure that allows all other Cores and the REC to be maximally
successful and impactful and will provide statistical support to users of ADRC resources especially junior
investigators and trainees.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil
-
批准号:10590405
-
项目类别:
-
资助金额:$367.18万
-
财政年份:2023
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Use and Impact of Novel and Repurposed Therapeutics for Alzheimer's Disease and Related Dementia in Diverse Populations
-
批准号:10655203
-
项目类别:
-
资助金额:$32.1万
-
财政年份:2023
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Core H: Religious Orders Study Core
-
批准号:10264500
-
项目类别:
-
资助金额:$70.65万
-
财政年份:2021
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Core A: Administrative Core
-
批准号:10472763
-
项目类别:
-
资助金额:$26.61万
-
财政年份:2021
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Core A: Administrative Core
-
批准号:10264494
-
项目类别:
-
资助金额:$26.61万
-
财政年份:2021
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Core H: Religious Orders Study Core
-
批准号:10472772
-
项目类别:
-
资助金额:$70.65万
-
财政年份:2021
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Core H: Religious Orders Study Core
-
批准号:10669651
-
项目类别:
-
资助金额:$70.65万
-
财政年份:2021
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Core A: Administrative Core
-
批准号:10669634
-
项目类别:
-
资助金额:$26.61万
-
财政年份:2021
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain
-
批准号:10404653
-
项目类别:
-
资助金额:$71.38万
-
财政年份:2019
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain
-
批准号:10172823
-
项目类别:
-
资助金额:$73.29万
-
财政年份:2019
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain
-
批准号:10655334
-
项目类别:
-
资助金额:$69.25万
-
财政年份:2019
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
-
批准号:9789157
-
项目类别:
-
资助金额:$164.86万
-
财政年份:2018
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
-
批准号:10251981
-
项目类别:
-
资助金额:$224.23万
-
财政年份:2018
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
-
批准号:10475098
-
项目类别:
-
资助金额:$272.88万
-
财政年份:2018
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
-
批准号:10375865
-
项目类别:
-
资助金额:$41.66万
-
财政年份:2018
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Integration of immune cell subtypes across diseases & tissue
-
批准号:10518099
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2018
-
负责人:DAVID ALAN BENNETT
-
依托单位:
A shared foundation for single genetic investigations of immune responses
-
批准号:10518096
-
项目类别:
-
资助金额:$15.55万
-
财政年份:2018
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
-
批准号:10075554
-
项目类别:
-
资助金额:$18.12万
-
财政年份:2018
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
-
批准号:10013100
-
项目类别:
-
资助金额:$305.0万
-
财政年份:2018
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Genome-wide Profiling of Brain DNA Hydroxymethylome in Alzheimer?sDisease
-
批准号:9816512
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2016
-
负责人:DAVID ALAN BENNETT
-
依托单位:
海外基金